On Air Now

Listen

Listen Live Now » 94.1 FM Jackson, Michigan

Weather

Current Conditions(Holt,MI 48842)

More Weather »
37° Feels Like: 31°
Wind: SE 7 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Partly Cloudy 46°

Tonight

Mostly Cloudy 32°

Tomorrow

Partly Cloudy 62°

Alerts

Pfizer gets new rebuff from UK cost body for cancer drug

A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. Pfizer Inc. REUTERS/Francois Lenoir
A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. Pfizer Inc. REUTERS/Francois Lenoir

LONDON (Reuters) - Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was turned down for use on the state health service.

The National Institute for Health and Clinical Excellence (NICE) said on Thursday the new treatment was not a cost-effective use of National Health Service resources.

The decision follows a similar rebuff for Pfizer's lung cancer drug Xalkori on Wednesday.

In both cases, the NICE recommendations are preliminary and subject to further consultation.

(Reporting by Ben Hirschler; Editing by Mark Potter)

Comments